A28 Therapeutics

A28 Therapeutics is a Clinical-stage biopharmaceutical company developing targeted oncolytic peptides (TOPs) for treating cancer.

This record contains identity and selected historical facts. Business areas, products and practical answers have not been added.

Data formats & record details

Download this profile and inspect its supporting evidence.

Data access & reuse

Entity ID
urn:readyscan:entity:a28-therapeutics-q139829650
Material fingerprint
fnv1a64:ca4e30c6fe186816
Entity revision
fnv1a64:ae0ac04a616e6ba7
Published
2026-07-29
Modified
2026-07-29
Source summary
A28 Therapeutics: Clinical-stage biopharmaceutical company developing targeted oncolytic peptides (TOPs) for treating cancer. Website: https://www.a28therapeutics.com